Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Accumulated Expenses (2018 - 2025)

Historic Accumulated Expenses for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $25.0 million.

  • Viemed Healthcare's Accumulated Expenses rose 2554.98% to $25.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.0 million, marking a year-over-year increase of 2554.98%. This contributed to the annual value of $20.2 million for FY2024, which is 1467.17% up from last year.
  • According to the latest figures from Q3 2025, Viemed Healthcare's Accumulated Expenses is $25.0 million, which was up 2554.98% from $18.6 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Accumulated Expenses ranged from a high of $25.0 million in Q3 2025 and a low of $8.7 million during Q1 2022
  • In the last 5 years, Viemed Healthcare's Accumulated Expenses had a median value of $14.1 million in 2024 and averaged $14.5 million.
  • As far as peak fluctuations go, Viemed Healthcare's Accumulated Expenses plummeted by 3554.47% in 2021, and later surged by 7504.51% in 2023.
  • Over the past 5 years, Viemed Healthcare's Accumulated Expenses (Quarter) stood at $8.9 million in 2021, then increased by 24.98% to $11.1 million in 2022, then soared by 58.47% to $17.6 million in 2023, then grew by 14.67% to $20.2 million in 2024, then rose by 24.06% to $25.0 million in 2025.
  • Its last three reported values are $25.0 million in Q3 2025, $18.6 million for Q2 2025, and $17.5 million during Q1 2025.